Is PET the future of nuclear medicine?

Dual-Threshold Contouring for [68Ga]Ga-DOTATATE PET/CT and Correlation with Overall Survival in Patients with Neuroendocrine Neoplasms.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

The innovation logic cycle of nuclear medicine: Translation, adoption, and reinvention across 130 years.

Seminars in nuclear medicine·2026

Efficacy of peptide receptor radionuclide therapy in patients with oligodiscordant gastroenteropancreatic neuroendocrine tumours.

European journal of nuclear medicine and molecular imaging·2026

PET/CT contouring techniques in neuroendocrine neoplasms: a state-of-the-art scoping review.

EJNMMI reports·2026

Somatostatin receptor PET response assessment framework for patients with neuroendocrine tumours (V1.0): a modified Delphi consensus from the European Neuroendocrine Tumor Society (endorsed by EANM and NANETS).

The Lancet. Oncology·2026

[177Lu]Lu-DOTATATE PRRT and CAPTEM chemotherapy for pancreas and small bowel neuroendocrine tumours: The AGITG CONTROL NETS Multi-centre randomized trial.

European journal of cancer (Oxford, England : 1990)·2026

High-contrast somatostatin receptor imaging of meningiomas with [¹⁸F]SiTATE PET/CT.

European journal of nuclear medicine and molecular imaging·2026

Associations of visceral adipose tissue metabolism with DMN-centered cross-network metabolic expression concordance and cognitive impairment in Alzheimer's disease.

European journal of nuclear medicine and molecular imaging·2026

Prognostic value of Amyloid PET in Real-World Amnestic MCI: Influence of reader experience and interpretation method.

European journal of nuclear medicine and molecular imaging·2026

Integrated 18F-NOTA-FAPI-04 PET/MRI for quantitative assessment of disease activity in thyroid-associated ophthalmopathy.

European journal of nuclear medicine and molecular imaging·2026

Diagnostic value of surveillance 18F-FDG PET/CT for detecting recurrent non-small cell lung cancer after curative resection: a multicentre retrospective cohort study.

European journal of nuclear medicine and molecular imaging·2026

Clinical impact of routine second‑opinion reading of [¹⁸F]FDG‑PET/CT in newly diagnosed invasive bladder cancer: A multicentre study in a centralised referral network.

European journal of nuclear medicine and molecular imaging·2026

Neuropsychiatric and multisystem toxicity following recreational inhalation of tiletamine-zolazepam (Zoletil 50): a retrospective case series with two-year prospective follow-up.

Journal of neurology·2026

Bioactive Collagen Peptides in Veterinary and Biomedical Science-Part II: The Gut-Collagen Peptide Axis, Bile Acid Signaling, and Translational Therapeutic Applications.

Veterinary sciences·2026

Effects of Vonoprazan on Isolated Rat Lower Esophageal Sphincter and Ileum.

Pharmaceuticals (Basel, Switzerland)·2026

In Vivo Metabolite Formation and In Vitro Cytochrome P450-Mediated Metabolism of Vonoprazan in Horses.

Metabolites·2026

Dried blood spot-based omega-3 fatty acid status assessment in dogs: The Omega-3 Index concept and its dermatological perspective - Short communication.

Acta veterinaria Hungarica·2026

Multimodal PET Imaging Unveils Early Metabolic Compensation Mechanisms and Dopaminergic Degeneration in Parkinson's Disease.

Cerebellum (London, England)·2026

Related Experiment Videos

Is PET the future of nuclear medicine?

Related Concept Videos

Dual-Threshold Contouring for [68Ga]Ga-DOTATATE PET/CT and Correlation with Overall Survival in Patients with Neuroendocrine Neoplasms.

The innovation logic cycle of nuclear medicine: Translation, adoption, and reinvention across 130 years.

Efficacy of peptide receptor radionuclide therapy in patients with oligodiscordant gastroenteropancreatic neuroendocrine tumours.

PET/CT contouring techniques in neuroendocrine neoplasms: a state-of-the-art scoping review.

Somatostatin receptor PET response assessment framework for patients with neuroendocrine tumours (V1.0): a modified Delphi consensus from the European Neuroendocrine Tumor Society (endorsed by EANM and NANETS).

[177Lu]Lu-DOTATATE PRRT and CAPTEM chemotherapy for pancreas and small bowel neuroendocrine tumours: The AGITG CONTROL NETS Multi-centre randomized trial.

High-contrast somatostatin receptor imaging of meningiomas with [¹⁸F]SiTATE PET/CT.

Associations of visceral adipose tissue metabolism with DMN-centered cross-network metabolic expression concordance and cognitive impairment in Alzheimer's disease.

Prognostic value of Amyloid PET in Real-World Amnestic MCI: Influence of reader experience and interpretation method.

Integrated 18F-NOTA-FAPI-04 PET/MRI for quantitative assessment of disease activity in thyroid-associated ophthalmopathy.

Diagnostic value of surveillance 18F-FDG PET/CT for detecting recurrent non-small cell lung cancer after curative resection: a multicentre retrospective cohort study.

Clinical impact of routine second‑opinion reading of [¹⁸F]FDG‑PET/CT in newly diagnosed invasive bladder cancer: A multicentre study in a centralised referral network.

Neuropsychiatric and multisystem toxicity following recreational inhalation of tiletamine-zolazepam (Zoletil 50): a retrospective case series with two-year prospective follow-up.

Bioactive Collagen Peptides in Veterinary and Biomedical Science-Part II: The Gut-Collagen Peptide Axis, Bile Acid Signaling, and Translational Therapeutic Applications.

Effects of Vonoprazan on Isolated Rat Lower Esophageal Sphincter and Ileum.

In Vivo Metabolite Formation and In Vitro Cytochrome P450-Mediated Metabolism of Vonoprazan in Horses.

Dried blood spot-based omega-3 fatty acid status assessment in dogs: The Omega-3 Index concept and its dermatological perspective - Short communication.

Multimodal PET Imaging Unveils Early Metabolic Compensation Mechanisms and Dopaminergic Degeneration in Parkinson's Disease.

Related Experiment Videos

Is PET the future of nuclear medicine?

Related Concept Videos

Related Articles